Young patients with colorectal cancer often had more aggressive forms of the disease, like signet-ring cell and mucinous ...

Methods: A total of 499 T1 colorectal carcinomas ... significantly higher in lesions featuring poorly differentiated/mucinous adenocarcinoma, submucosal invasion ≥ 1800 μm, vascular invasion ...

Mucinous cystic neoplasms (MCNs) encompass a spectrum ranging from benign but potentially malignant to carcinoma with a very aggressive behavior. There is often heterogeneity within the lesions with ...

Camrelizumab is under clinical development by Elevar Therapeutics and currently in Pre-Registration for Hepatocellular Carcinoma.

She had been treated for rectal adenocarcinoma 7 years previously ... a Crohn's-like surrounding lymphocytic reaction, mucinous or signet-ring cell differentiation, or a medullary growth pattern.

Camrelizumab is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Pancreatic Cancer.